/BTSG
BTSG Stock - BrightSpring Health Services, Inc. Common Stock
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$37.49+2.32%
+$0.85 (+2.32%) • Dec 19
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).56
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.26
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+2.8%upside
Target: $38.54
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BTSG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$37.12 – $37.86
TARGET (TP)$38.55
STOP LOSS$34.49
RISK/REWARD1:0.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.36
52W High$37.94
52W Low$15.26
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $11.27B | $8.83B | $7.72B | $6.70B | $5.58B |
| Gross Profit | $1.59B | $1.43B | $1.35B | $1.25B | $1.05B |
| Gross Margin | 14.1% | 16.2% | 17.5% | 18.6% | 18.8% |
| Operating Income | $206.37M | $147.18M | $187.83M | $234.18M | $165.19M |
| Net Income | $-18,062,000 | $-154,603,000 | $-53,907,000 | $49.80M | $20.81M |
| Net Margin | -0.2% | -1.8% | -0.7% | 0.7% | 0.4% |
| EPS | $-0.09 | $-0.90 | $-0.31 | $0.29 | $0.12 |
Company Overview
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
13
93%
Hold / Neutral
1
7%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
13 Bullish1 Neutral/Bearish
Price Targets
$22
Average Target
↓ 41.2% Downside
Now
$12
Low
$22
Average
$45
High
Based on 16 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 12th 2025 | KeyBanc Capital Markets | Upgrade | Overweight | $45 |
| December 11th 2025 | Stephens | Initiation | Overweight | $44 |
| December 8th 2025 | William Blair | Initiation | Outperform | - |
| November 13th 2025 | BMO Capital Markets | Initiation | Outperform | $40 |
| June 23rd 2025 | TD Cowen | Initiation | Buy | $37 |
| December 12th 2024 | CJS Securities | Initiation | Market Outperform | - |
| October 11th 2024 | KeyBanc Capital Markets | Initiation | Sector Weight | - |
| June 21st 2024 | BTIG Research | Initiation | Buy | $15 |
| March 6th 2024 | HSBC Securities | Initiation | Buy | $13 |
| February 27th 2024 | Deutsche Bank | Upgrade | Buy | $11.5 |
| February 20th 2024 | Guggenheim | Initiation | Buy | $15 |
| February 20th 2024 | Leerink Partners | Initiation | Outperform | $15 |
| February 20th 2024 | BofA Securities | Initiation | Buy | $14 |
| February 20th 2024 | UBS | Initiation | Buy | $15 |
| February 20th 2024 | Morgan Stanley | Initiation | Overweight | $18 |
Earnings History & Surprises
BTSGBeat Rate
63%
Last 8 quarters
Avg Surprise
+7.9%
EPS vs Estimate
Beats / Misses
5/3
Last 12 quarters
Latest EPS
$0.30
Q4 2025
EPS Surprise History
Q1 24
-140.0%
$-0.06vs$0.15
Q2 24
+100.0%
$0.12vs$0.06
Q3 24
-41.2%
$0.10vs$0.17
Q4 24
-38.9%
$0.11vs$0.18
Q1 25
+15.8%
$0.22vs$0.19
Q2 25
+137.5%
$0.19vs$0.08
Q3 25
+15.8%
$0.22vs$0.19
Q4 25
+13.9%
$0.30vs$0.26
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 30, 2026 | — | — | — | — |
Q1 2026 | Mar 5, 2026 | $0.34 | — | — | — |
Q4 2025 | Oct 31, 2025 | $0.26 | $0.30 | +13.9% | ✓ BEAT |
Q3 2025 | Aug 1, 2025 | $0.19 | $0.22 | +15.8% | ✓ BEAT |
Q2 2025 | May 2, 2025 | $0.08 | $0.19 | +137.5% | ✓ BEAT |
Q1 2025 | Mar 6, 2025 | $0.19 | $0.22 | +15.8% | ✓ BEAT |
Q4 2024 | Nov 1, 2024 | $0.18 | $0.11 | -38.9% | ✗ MISS |
Q3 2024 | Aug 2, 2024 | $0.17 | $0.10 | -41.2% | ✗ MISS |
Q2 2024 | May 2, 2024 | $0.06 | $0.12 | +100.0% | ✓ BEAT |
Q1 2024 | Feb 29, 2024 | $0.15 | $-0.06 | -140.0% | ✗ MISS |
Q1 2024 | Jan 26, 2024 | — | $-0.76 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.02 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.12 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.33 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-0.13 | — | — |
Q3 2021 | Sep 29, 2021 | — | $0.19 | — | — |
Q2 2021 | Jun 29, 2021 | — | $0.12 | — | — |
Q1 2021 | Mar 30, 2021 | — | $0.21 | — | — |
Latest News
Mizuho Maintains Outperform on BrightSpring Health, Raises Price Target to $42
📈 PositiveBenzinga•Dec 18, 2025, 01:12 PM
Keybanc Upgrades BrightSpring Health to Overweight, Announces $45 Price Target
📈 PositiveBenzinga•Dec 12, 2025, 11:46 AM
Stephens & Co. Initiates Coverage On BrightSpring Health with Overweight Rating, Announces Price Target of $44
📈 PositiveBenzinga•Dec 11, 2025, 01:55 PM
B of A Securities Maintains Buy on BrightSpring Health, Raises Price Target to $41
📈 PositiveBenzinga•Dec 9, 2025, 05:51 PM
William Blair Initiates Coverage On BrightSpring Health with Outperform Rating
📈 PositiveBenzinga•Dec 8, 2025, 02:33 PM
Watching BrightSpring Health Services; Hearing Investor Business Daily SwingTrader Buys Stock
📈 PositiveBenzinga•Dec 5, 2025, 04:50 PM
Watching BrightSpring Health Services; Hearing Investor Business Daily SwingTrader Buys Stock
📈 PositiveBenzinga•Nov 19, 2025, 03:24 PM
BMO Capital Initiates Coverage On BrightSpring Health with Outperform Rating, Announces Price Target of $40
📈 PositiveBenzinga•Nov 13, 2025, 11:09 AM
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $39
📈 PositiveBenzinga•Nov 12, 2025, 03:17 PM
BTIG Maintains Buy on BrightSpring Health, Raises Price Target to $41
📈 PositiveBenzinga•Oct 29, 2025, 05:58 PM
UBS Maintains Buy on BrightSpring Health, Raises Price Target to $42
📈 PositiveBenzinga•Oct 29, 2025, 03:44 PM•Also:
BrightSpring Health Raises FY2025 Sales Guidance from $12.400B-$12.700B to $12.500B-$12.800B vs $12.536B Est
📈 PositiveBenzinga•Oct 28, 2025, 08:07 PM
BrightSpring Health Q3 Adj. EPS $0.30 Misses $0.32 Estimate, Sales $3.334B Beat $3.308B Estimate
➖ NeutralBenzinga•Oct 28, 2025, 08:06 PM
Reported Earlier, BrightSpring Prices 15M Share Secondary Offering With Concurrent 1.5M Share Buyback At Underwriter Purchase Price
➖ NeutralBenzinga•Oct 21, 2025, 06:31 AM
BrightSpring Health Raises FY2025 Sales Guidance from $12.200B-$12.600B to $12.400B-$12.700B vs $12.509B Est
📈 PositiveBenzinga•Oct 20, 2025, 08:42 PM
BrightSpring Health Services shares are trading lower after the company announced a $50 million offering of 15 million shares by existing stockholders. The company reported preliminary Q3 financial results.
📉 NegativeBenzinga•Oct 20, 2025, 08:33 PM
BrightSpring Health Services Announces Secondary Offering Of15M Shares By Existing Stockholders; Company To Repurchase Up To $50M Of Shares
➖ NeutralBenzinga•Oct 20, 2025, 08:31 PM
BrightSpring Health Sees Prelim Q3 Adj EPS $0.30 vs $0.27 Est; Sees Sales $3.334B vs $3.167B Est
📈 PositiveBenzinga•Oct 20, 2025, 08:30 PM
Mizuho Maintains Outperform on BrightSpring Health, Raises Price Target to $32
📈 PositiveBenzinga•Oct 17, 2025, 01:15 PM
BrightSpring Health Services Will Replace Veritex Holdings In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Monday, October 20
📈 PositiveBenzinga•Oct 14, 2025, 09:20 PM•Also:
Frequently Asked Questions about BTSG
What is BTSG's current stock price?
BrightSpring Health Services, Inc. Common Stock (BTSG) is currently trading at $37.49 per share. The stock has moved +2.32% today.
What is the analyst price target for BTSG?
The average analyst price target for BTSG is $38.55, based on 1 analyst.
What sector is BrightSpring Health Services, Inc. Common Stock in?
BrightSpring Health Services, Inc. Common Stock operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is BTSG's market cap?
BrightSpring Health Services, Inc. Common Stock has a market capitalization of $6.76 billion, making it a mid-cap company.
Does BTSG pay dividends?
No, BrightSpring Health Services, Inc. Common Stock does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBRKR
Bruker Corporation
$46.48
Mkt Cap: $7.1B
CHE
Chemed Corporation
$435.33
Mkt Cap: $6.4B
CRSP
CRISPR Therapeutics AG
$55.86
Mkt Cap: $4.9B
HQY
HealthEquity, Inc.
$95.50
Mkt Cap: $8.3B
IRTC
iRhythm Technologies, Inc.
$174.17
Mkt Cap: $5.6B
KRYS
Krystal Biotech, Inc.
$240.80
Mkt Cap: $7.0B
MMSI
Merit Medical Systems, Inc.
$87.70
Mkt Cap: $5.2B
RDNT
RadNet, Inc.
$76.68
Mkt Cap: $5.9B
STVN
Stevanato Group S.p.A.
$20.53
Mkt Cap: $5.6B
TFX
Teleflex Incorporated
$121.89
Mkt Cap: $5.4B
Explore stocks similar to BTSG for comparison